Novel mechanisms of action of emerging therapies of hereditary thrombotic thrombocytopenic purpura

X. Long Zheng
DOI: https://doi.org/10.1080/17474086.2024.2356763
2024-05-21
Expert Review of Hematology
Abstract:Introduction Hereditary thrombotic thrombocytopenic purpura (hTTP) is caused by deficiency of plasma ADAMTS13 activity, resulting from ADAMTS13 mutations. ADAMTS13 cleaves ultra large von Willebrand factor (VWF), thus reducing its multimer sizes. Hereditary deficiency of plasma ADAMTS13 activity leads to the formation of excessive platelet-VWF aggregates in small arterioles and capillaries, resulting in hTTP.
hematology
What problem does this paper attempt to address?